Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT00003723. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01032057. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00006117. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00902291. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov study NCT00003851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00082862. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation
ClinicalTrials.gov study NCT02159248. IPD Sharing: Not stated. Countries: 1. Publications: 39.
Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00005991. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study
ClinicalTrials.gov study NCT00747097. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients
ClinicalTrials.gov study NCT05168527. IPD Sharing: NO. Countries: 1. Publications: 42.
A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma
ClinicalTrials.gov study NCT01564251. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
ClinicalTrials.gov study NCT04308174. IPD Sharing: NO. Countries: 1. Publications: 3.
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
ClinicalTrials.gov study NCT02460887. IPD Sharing: Not stated. Countries: 1. Publications: 12.
A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01019382. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00147875. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCL
ClinicalTrials.gov study NCT03795571. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
ClinicalTrials.gov study NCT00410982. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
ClinicalTrials.gov study NCT00001449. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma
ClinicalTrials.gov study NCT01869023. IPD Sharing: YES. Countries: 1. Publications: 1.
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
ClinicalTrials.gov study NCT04595994. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.